Source: International Congress 2019 – New insights into respiratory function testing
Disease area: Airway diseases, Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
N. Domnik (Kingston, Canada), M. James (Kingston, Canada), C. Ciavaglia (Kingston, Canada), H. Driver (Kingston, Canada), S. Crinion (Kingston, Canada), J. Neder (Kingston, Canada), D. O'Donnell (Kingston, Canada). Overnight deterioration of supine respiratory mechanics in COPD: impact of nocturnal aclidinium bromide/formoterol fumarate. 478

Member's Comments

No comment yet.

Related content which might interest you: The effects of short-term nocturnal non-invasive ventilation (NIV) on respiratory muscle functional capacity in COPD patients with chronic hypercapnic respiratory failure (CHRF) Source: Virtual Congress 2021 – New insights into the pathophysiology and prognosis of COPD Year: 2021 Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 86-94 Year: 2004 Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006 Formoterol or tiotropium bromide do not influence isolated nocturnal hypoxemia in stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005 Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD Source: Eur Respir J 2005; 26: 1016-1023 Year: 2005 The effects of salmeterol on respiratory muscle activity and ventilatory mechanics in poorly reversible COPD Source: Eur Respir J 2003; 22: Suppl. 45, 209s Year: 2003 Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD Source: International Congress 2014 – Clinical physiology and respiratory muscles Year: 2014 Effect of nasal CPAP therapy on functional respiratory parameters and cardiopulmonary exercise test in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD Source: Eur Respir J 2006; 28: Suppl. 50, 33s Year: 2006 Pursed-lip breathing ventilation for the treatment of hypercapnic respiratory failure in COPD Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Early effect of ipratropium bromide on the ventilatory mechanics of mechanically ventilated chronic obstructive pulmonary disease patients Source: Eur Respir J 2001; 18: Suppl. 33, 72s Year: 2001 Effect of heliox breathing on locomotor and respiratory muscle oxygen delivery during exercise in COPD patients with or without dynamic hyperinflation Source: Annual Congress 2011 - Altered mechanisms during exercise in disease Year: 2011 Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD Source: Eur Respir J 2004; 23: 825-831 Year: 2004 An overnight comparison of two ventilators used in the treatment of chronic respiratory failure Source: Eur Respir J 2002; 20: 942-945 Year: 2002 Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD Source: Eur Respir J 2001; 17: 1132-1137 Year: 2001 Predictors of nocturnal desaturation in COPD patients with mild daytime hypoxaemia Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003 Montelukast can improve isolated nocturnal hypoxemia in stable COPD patients with positive reversibility test Source: Eur Respir J 2006; 28: Suppl. 50, 427s Year: 2006 Critical inspiratory constraints and excess ventilation are superior to breathing reserve in predicting exertional dyspnoea in COPD Source: International Congress 2019 – Exploring exercise responses in respiratory diseases Year: 2019 Inhaled vilanterol trifenatate/fluticasone furoate (VFF) improves respiratory muscle function and walking performance in severe COPD without change in pulmonary function Source: International Congress 2017 – Management of COPD Year: 2017